GABA and Its Receptors in Epilepsy
Authors:
- Sabine FurtingerSFSabine Furtinger
- Christoph SchwarzerCSChristoph Schwarzer
- Susanne PirkerSPSusanne Pirker
- 1 January 2004
- book chapter
- Published by Springer Nature
- Vol. 548, 92-103
Abstract
γ-aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the mammalian brain. It acts through 2 classes of receptors, GABAA receptors that are ligand-operated on channels and the G-protein-coupled metabotropic GABAB receptors. Impairment of GABAergic transmission by genetic mutations or application of GABA receptor antagonists induces epileptic seizures, whereas drugs augmenting GABAergic transmission are used for antiepileptic therapy. In animal epilepsy models and in tissue from patients with temporal lobe epilepsy, loss in subsets of hippocampal GABA neurons is observed. On the other hand, electrophysiological and neurochemical studies indicate a compensatory increase in GABAergic transmission at certain synapses. Also, at the level of the GABAA receptor, neurodegeneration-induced loss in receptors is accompanied by markedly altered expression of receptor subunits in the dentate gyrus and other parts of the hippocampal formation, indicating altered physiology and pharmacology of GABAA receptors. Such mechanisms may be highly relevant for seizure induction, augmentation of endogenous protective mechanisms, and resistance to antiepileptic drug therapy. Other studies suggest a role of GABAB receptors in absence seizures. Presynaptic GABAB receptors suppress neurotransmitter release. Depending on whether this action is exerted in GABAergic or glutamatergic neurons, there may be anticonvulsant or proconvulsant actions. γ—aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the mammalian brain.1 It acts through 2 classes of receptors, GABAA receptors that are ligand-operated ion channels and the G-protein-coupled metabotropic GABAB receptors (for review see ref. 2). GABAergic neurons are ubiquitously distributed and encompass a fundamental role in processing and integration of all neuronal functions. It is therefore not surprising that blockade of the fast inhibitory GABAA receptors by bicuculline, pentylenetetrazol or picrotoxin causes severe motor seizures in experimental animals.3,4 It has therefore been suggested that dysfunction of the GABAergic system may have a fundamental role in the propagation of acute seizures and in the manifestation of epilepsy syndromes. Indeed, mutant mice lacking the enzyme glutamate decarboxylase (GAD) or certain subunits of GABAA receptors are prone to spontaneous epileptic seizures.5–7 In the same way, patients with auto-antibodies to the enzyme GAD-67 suffer from the so called Stiff-man-syndrome, and often develop also epilepsy.8,9 One of the most serious and frequent epilepsy syndromes is temporal lobe epilepsy (TLE). It is initiated by prolonged febrile seizures or status epilepticus, and takes years or even more than a decade until it is manifested.10,11 In the clinic, TLE is difficult to treat, and patients frequently become resistant to drug therapy.12 Repeated and prolonged seizures may also contribute to the severe neuronal damage observed in the temporal lobe, notably in the hippocampus, entorhinal cortex, amygdala and other brain areas.13,14 One of the most typical features is the severe loss of principal neurons in the hippocampus proper, notably in sectors CA1 and CM3, whereas granule cells of the dentate gyrus, and pyramidal neurons of the sector CA2 and the subiculum, are relatively spared.10,15 Because of its clinical relevance and the feature that TLE develops over a prolonged “silent” period, considerable effort has been made through the past decades to investigate its pathophysiology. Animal models mimicking different aspects of TLE, like the induction by severe status epilepticus, subsequent epileptogenesis, and manifestation of spontaneous seizure activity, have been developed.16–19 These models, and hippocampal tissue specimens obtained at surgery from patients with drug-resistant TLE, became valuable objects for studying the pathophysiology of the disease (see refs. 20–23).Keywords
This publication has 126 references indexed in Scilit:
- Epileptogenesis and Enhanced Prepulse Inhibition in GABAB1-Deficient MiceMolecular and Cellular Neuroscience, 2001
- The alteration of γ-aminobutyric acid-transaminase expression in the gerbil hippocampus induced by seizureNeurochemistry International, 2001
- GABAB Receptors: A New Paradigm in G Protein SignalingMolecular and Cellular Neuroscience, 2000
- Quantitative neuropathology and quantitative magnetic resonance imaging of the hippocampus in temporal lobe epilepsyAnnals of Neurology, 1997
- Experimental status epilepticus alters γ‐aminobutyric acid type A receptor function in CA1 pyramidal neuronsAnnals of Neurology, 1995
- Baclofen prevents rapid amygdala kindling in adult ratsCellular and Molecular Life Sciences, 1994
- Dormancy of Inhibitory Interneurons in a Model of Temporal Lobe EpilepsyScience, 1993
- Inhibition of l-glutamate uptake into synaptic vesiclesNeuroscience Letters, 1992
- Long term increase of glutamate decarboxylase mRNA in a rat model of temporal lobe epilepsyNeuron, 1990
- Autoantibodies to Glutamic Acid Decarboxylase in a Patient with Stiff-Man Syndrome, Epilepsy, and Type I Diabetes MellitusNew England Journal of Medicine, 1988